These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 36119523)
1. Bioactive peptides from venoms against glioma progression. Majc B; Novak M; Lah TT; Križaj I Front Oncol; 2022; 12():965882. PubMed ID: 36119523 [TBL] [Abstract][Full Text] [Related]
2. Anticancer potential of bioactive peptides from animal sources (Review). Wang L; Dong C; Li X; Han W; Su X Oncol Rep; 2017 Aug; 38(2):637-651. PubMed ID: 28677775 [TBL] [Abstract][Full Text] [Related]
3. Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies. Attia N; Mashal M; Pemminati S; Omole A; Edmondson C; Jones W; Priyadarshini P; Mughal T; Aziz P; Zenick B; Perez A; Lacken M Cells; 2021 Dec; 11(1):. PubMed ID: 35011678 [TBL] [Abstract][Full Text] [Related]
4. The Renin-Angiotensin System in the Tumor Microenvironment of Glioblastoma. O'Rawe M; Kilmister EJ; Mantamadiotis T; Kaye AH; Tan ST; Wickremesekera AC Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439159 [TBL] [Abstract][Full Text] [Related]
6. Cediranib, a pan-inhibitor of vascular endothelial growth factor receptors, inhibits proliferation and enhances therapeutic sensitivity in glioblastoma cells. Momeny M; Shamsaiegahkani S; Kashani B; Hamzehlou S; Esmaeili F; Yousefi H; Irani S; Mousavi SA; Ghaffari SH Life Sci; 2021 Dec; 287():120100. PubMed ID: 34715143 [TBL] [Abstract][Full Text] [Related]
7. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review. Schönthal AH; Swenson SD; Chen TC; Markland FS Biochem Pharmacol; 2020 Nov; 181():114149. PubMed ID: 32663453 [TBL] [Abstract][Full Text] [Related]
8. Mutual Influence of ROS, pH, and CLIC1 Membrane Protein in the Regulation of G Peretti M; Raciti FM; Carlini V; Verduci I; Sertic S; Barozzi S; Garré M; Pattarozzi A; Daga A; Barbieri F; Costa A; Florio T; Mazzanti M Mol Cancer Ther; 2018 Nov; 17(11):2451-2461. PubMed ID: 30135216 [TBL] [Abstract][Full Text] [Related]
9. CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A Yan A; Joachims ML; Thompson LF; Miller AD; Canoll PD; Bynoe MS J Neurosci; 2019 May; 39(22):4387-4402. PubMed ID: 30926752 [TBL] [Abstract][Full Text] [Related]
10. Chaperone-Mediated Autophagy Ablation in Pericytes Reveals New Glioblastoma Prognostic Markers and Efficient Treatment Against Tumor Progression. Molina ML; García-Bernal D; Salinas MD; Rubio G; Aparicio P; Moraleda JM; Martínez S; Valdor R Front Cell Dev Biol; 2022; 10():797945. PubMed ID: 35419364 [No Abstract] [Full Text] [Related]
11. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment. Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy: Advancing glioblastoma treatment-A narrative review of scientific studies. Tiwari S; Han Z Cancer Rep (Hoboken); 2023 Dec; 7(2):e1947. PubMed ID: 38069593 [TBL] [Abstract][Full Text] [Related]
13. Multi-targeting sodium and calcium channels using venom peptides for the treatment of complex ion channels-related diseases. Cardoso FC Biochem Pharmacol; 2020 Nov; 181():114107. PubMed ID: 32579958 [TBL] [Abstract][Full Text] [Related]
14. HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation. Cobbs C; Khan S; Matlaf L; McAllister S; Zider A; Yount G; Rahlin K; Harkins L; Bezrookove V; Singer E; Soroceanu L Oncotarget; 2014 Feb; 5(4):1091-100. PubMed ID: 24658280 [TBL] [Abstract][Full Text] [Related]
15. The Interplay of Microtubules with Mitochondria-ER Contact Sites (MERCs) in Glioblastoma. Grespi F; Vianello C; Cagnin S; Giacomello M; De Mario A Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454156 [TBL] [Abstract][Full Text] [Related]